MedPath

NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study

Recruiting
Conditions
Cardiovascular Diseases
Non-Alcoholic Fatty Liver Disease
Metabolic Syndrome
Interventions
Behavioral: Digital wearable and AI-human symbiotic lifestyle intervention
First Posted Date
2024-01-18
Last Posted Date
2024-10-14
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
3000
Registration Number
NCT06211868
Locations
🇸🇬

NUS, Singapore, Singapore

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Phase 1
Active, not recruiting
Conditions
Castration-resistant Prostate Cancer
Prostate Cancer
Metastatic Cancer
Hormone Sensitive Prostate Cancer
Interventions
First Posted Date
2024-01-08
Last Posted Date
2024-01-08
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
10
Registration Number
NCT06193993
Locations
🇸🇬

National University Hospital, Singapore, Singapore

Real-time Early Detection of Nephrotoxicity by Urinary Biomarker Analysis With SeroFlow Technology

Not Applicable
Recruiting
Conditions
Acute Kidney Injury
Interventions
Diagnostic Test: AKI risk screening using RenaFAST POCT test kits
First Posted Date
2023-11-09
Last Posted Date
2023-11-09
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
150
Registration Number
NCT06124885
Locations
🇸🇬

National University Hospital, Singapore, Singapore

DREAMS-OT Trial: Delirium Reduction Through Early Activation in Motivating and Sleep Promoting Routines: A Randomized Controlled Trial of Occupational Therapy for ICU Patients After Coronary Artery Bypass Graft (CABG) Surgery

Not Applicable
Not yet recruiting
Conditions
Delirium, Postoperative
Interventions
Other: DREAMS-OT
First Posted Date
2023-10-30
Last Posted Date
2023-10-30
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
300
Registration Number
NCT06107517

Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations

Phase 2
Recruiting
Conditions
NSCLC
Interventions
First Posted Date
2023-10-02
Last Posted Date
2025-04-04
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
35
Registration Number
NCT06062823
Locations
🇸🇬

National University Hospital, Singapore, Singapore

The Platform for Interdisciplinary Cardiovascular-metabolic-neurovascular Diseases (PICMAN)

Recruiting
Conditions
Cardiometabolic Syndrome
First Posted Date
2023-10-02
Last Posted Date
2023-10-02
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
120
Registration Number
NCT06062836
Locations
🇸🇬

National University Health System, Singapore, Singapore

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Phase 1
Not yet recruiting
Conditions
HER2+ Advanced Breast Cancer
Other Solid Tumors
Interventions
Drug: Chimeric receptor T-cells + Trastuzumab
First Posted Date
2023-09-07
Last Posted Date
2023-10-30
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
36
Registration Number
NCT06027983

Weight Loss Interventions for Obesity

Not Applicable
Recruiting
Conditions
Ketogenic Dieting
Overweight
Weight Loss
Obesity
Interventions
Other: Healthy Ketogenic Ready-to-Eat Meals
Other: Healthy Ketogenic Diet
First Posted Date
2023-09-05
Last Posted Date
2023-09-05
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
50
Registration Number
NCT06022796
Locations
🇸🇬

National University Hospital, Singapore, Singapore

Treatment Outcome of Ortho MTA (BioMTA®) Cement vs AH Plus® Bioceramic Sealer (Dentsply).

Not Applicable
Recruiting
Conditions
Endodontic Disease
Interventions
Device: GP and AH Plus sealer
Device: Ortho MTA cement
First Posted Date
2023-08-09
Last Posted Date
2024-08-28
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
70
Registration Number
NCT05984940
Locations
🇸🇬

National University Hospital, Singapore, Singapore, Singapore

Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous Lesions

Not Applicable
Recruiting
Conditions
Gastric Cancer
Interventions
Device: SPECTRA IMDx™
First Posted Date
2023-08-04
Last Posted Date
2023-08-04
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
25
Registration Number
NCT05977478
Locations
🇸🇬

National University Hospital, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath